Actylis Executive and Leadership Team

Douglas Roth, the Chief Financial Officer at Actylis, directs the overarching financial architecture and capital allocation strategies for the organization. Managing fiscal health, the Chief Financial Officer oversees comprehensive budgeting, financial reporting, and risk management frameworks essential for supporting the global manufacturing footprint. Roth ensures that capital investments align with the long-term growth objectives of the company, particularly regarding the expansion of GMP and non-GMP facilities. By optimizing cost structures and enhancing liquidity, the Chief Financial Officer facilitates the procurement of critical raw materials across diverse international markets. Douglas Roth maintains rigorous oversight of financial compliance and regulatory standards, ensuring that all fiscal operations support the delivery of high-performance ingredients. Through precise financial planning, the Chief Financial Officer drives sustainable profitability and provides the necessary resources for the company to meet the complex requirements of the Life Sciences and Specialty Chemicals sectors.

Arpit Butala, the Director and Chief Financial Officer APAC at Actylis, manages the financial operations and strategic growth initiatives across the Asia-Pacific region. Overseeing regional fiscal performance, the Director and Chief Financial Officer APAC ensures that local sourcing hubs and manufacturing activities remain aligned with global corporate standards. Butala directs the integration of regional financial data into the broader corporate reporting structure, facilitating informed decision-making for the executive leadership team. Arpit Butala monitors market trends within the APAC territory to identify opportunities for expanding the portfolio of performance ingredients. By streamlining regional supply chain costs and enhancing operational efficiency, the Director and Chief Financial Officer APAC supports the company's mission to provide reliable solutions for unique manufacturing requirements. This leadership role involves coordinating with global stakeholders to maintain consistent quality documentation and regulatory compliance throughout the diverse and rapidly evolving Asia-Pacific market landscape.

Trae Etre, the Senior Vice President & Chief Financial Officer at Actylis, architects the enterprise-wide financial strategy and long-term economic planning. Overseeing the intersection of corporate finance and operational performance, the Senior Vice President & Chief Financial Officer drives initiatives that enhance the scalability of the global sourcing network. Etre manages the balance between internal manufacturing capabilities and external sourcing hubs to ensure maximum flexibility for customers. Trae Etre coordinates with the Board to evaluate strategic acquisitions and capital projects that strengthen the company's position in the Agriscience and Specialty Chemicals industries. By implementing robust financial controls and performance metrics, the Senior Vice President & Chief Financial Officer ensures that all business units operate with high efficiency. This role involves fostering transparency in financial reporting and maintaining strong relationships with investors, ultimately securing the financial foundation necessary for the company to deliver industry-leading standards of quality and regulatory compliance.

Keith Wilkinson, the President (North America) at Actylis, directs all commercial and operational activities across the North American market. Overseeing the regional manufacturing facilities and sourcing operations, the President (North America) ensures that the company meets the specific needs of the Life Sciences and Specialty Chemicals sectors. Wilkinson drives the execution of regional growth strategies, focusing on the delivery of high-quality raw materials and performance ingredients. Keith Wilkinson coordinates with cross-functional teams to maintain strict adherence to GMP standards and regulatory requirements throughout the North American supply chain. By fostering strong relationships with key customers and partners, the President (North America) expands the company's market presence and enhances service reliability. This leadership role involves optimizing regional logistics and production workflows to support the broader corporate mission of providing flexible, high-value solutions for complex manufacturing requirements within the competitive North American industrial landscape.

Damien O'Rourke, the President Global Life Sciences at Actylis, architects the strategic direction and product development roadmap for the Life Sciences division. Overseeing the global portfolio of GMP and non-GMP ingredients, the President Global Life Sciences ensures that the company provides cutting-edge solutions for pharmaceutical and biotechnology customers. O'Rourke directs the integration of global sourcing and manufacturing capabilities to meet the stringent quality and regulatory demands of the industry. Damien O'Rourke collaborates with technical and regulatory teams to ensure that all products exceed industry standards for documentation and compliance. By identifying emerging market needs and technological advancements, the President Global Life Sciences drives innovation across the international business units. This leadership role involves managing complex supply chains to ensure the consistent availability of critical raw materials, ultimately supporting the company's commitment to reliability and excellence in the global Life Sciences market.

Mark Bostel, the President, Global Nutrition and OTC at Actylis, directs the commercial strategy and operational execution for the nutrition and over-the-counter ingredient segments. Overseeing the global supply chain and product sourcing for these specific markets, the President, Global Nutrition and OTC ensures that the company delivers high-quality, compliant ingredients to manufacturers worldwide. Bostel manages the development of custom ingredient solutions tailored to the unique requirements of the nutrition industry. Mark Bostel coordinates with global sourcing hubs to maintain a robust and flexible inventory that meets the evolving demands of the OTC sector. By focusing on operational excellence and regulatory rigor, the President, Global Nutrition and OTC supports the company's mission to provide reliable raw materials. This leadership role involves driving market expansion and fostering long-term partnerships with key industry players, ensuring that the company remains a preferred supplier for high-performance nutrition and OTC ingredients.